
About this interview:
In this video interview, Maria Jison details more specifics about the mobile bus initiative undertaken by AstraZeneca to serve as satellite sites and provide the capability to directly work within the community and build genuine connections and trust while laying the groundwork for DCT/hybrid trials for greater accessibility. The full presentation was presented as part of the Mobile Tech in Clinical Trials September 2024 meeting, where this interview was recorded.
For more information, and to explore the upcoming DPHARM conference, you can visit DPHARMconference.com.